Bora Pharmaceuticals
Tracked across 2 events · 13 articles · First seen May 12, 2026 · Last active Jul 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Bora Pharmaceuticals is acquiring the GMP manufacturing operations of MacroGenics, Inc. for US$122.5 million, strengthening its biologics CDMO platform in the United States.
May 12, 2026 · 6 articles
Business
Impact: Bora Pharmaceuticals completed the acquisition of MacroGenics' manufacturing operations, expanding its biologics CDMO capabilities and establishing a significant US manufacturing platform. This strengthens its position in the pharmaceutical services industry.
Jul 02, 2026 · 7 articles
100
Bora Pharmaceuticals approved acquisition MacroGenicsBora Pharmaceuticals...
90
Bora Pharmaceuticals expanded capacityBora Pharmaceuticals...
80
Bora Pharmaceuticals will sign agreement MacroGenicsBora Pharmaceuticals...
ERGEN INTELLIGENCE
Track Bora Pharmaceuticals live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard